0001374339-21-000002.txt : 20210909 0001374339-21-000002.hdr.sgml : 20210909 20210909152135 ACCESSION NUMBER: 0001374339-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210909 DATE AS OF CHANGE: 20210909 EFFECTIVENESS DATE: 20210909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-412825 FILM NUMBER: 211244308 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 D 1 primary_doc.xml X0708 D LIVE 0001374339 ProMIS Neurosciences Inc. SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 415-341-5783 CANADA (FEDERAL LEVEL) 4203801 Canada Inc. AMORFIX LIFE SCIENCES LTD Corporation true Elliot Goldstein Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Eugene Williams Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Patrick Kirwin Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Neil Cashman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Richard Gregory Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Daniel Geffken Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4s 3E2 Executive Officer Johanne Kaplan Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer William Wyman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Biotechnology No Revenues 06b false 2021-08-25 true true true true true Each unit consists of one common share and one quarter of one common share purchase warrant. Each whole warrant is exercisable for one common share at an exercise price of $0.21 per common share until August 25, 2026. false 0 Ceros Financial Services, Inc. 37869 None None 1445 Research Blvd Suite 530 Rockville MD MARYLAND 20850 CA CALIFORNIA FL FLORIDA ID IDAHO IL ILLINOIS MA MASSACHUSETTS NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS false 24710516 18107000 6603516 The additional $6,603,516.00 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. false 34 12674900 true 0 Includes 7,921,813 compensation warrants to purchase one common share of common stock at a price of $0.16 per share at any time for up to 5 years. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false ProMIS Neurosciences Inc. Elliot Goldstein Elliot Goldstein CEO 2021-09-07